How to use medicines in children: Principles of paediatric clinical pharmacology

Journal of Paediatrics and Child Health

Volumn 43, Issue 3, 2007, Pages 107-111

  Sinha, Yashwant ^a,b,d   Cranswick, Noel E ^c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Children; Clinical trials; Medication; Off label prescribing

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; ARGININE; CAFFEINE; CLOBAZAM; CLONIDINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; DIAZEPAM; DIPHTHERIA TOXOID; INDOMETACIN; OMEPRAZOLE; PARACETAMOL; SALBUTAMOL; SPIRONOLACTONE; SULFANILAMIDE; THALIDOMIDE;

ASTHMA; ATTENTION DEFICIT DISORDER; AUSTRALIA; CHILD DEVELOPMENT; CHILD SAFETY; CLINICAL PHARMACOLOGY; DRUG ABSORPTION; DRUG CONTAMINATION; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG DOSE REGIMEN; DRUG EXCRETION; DRUG INDUSTRY; DRUG LABELING; DRUG LEGISLATION; DRUG MARKETING; DRUG METABOLISM; DRUG SAFETY; DRUG USE; EPILEPTIC STATE; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; LICENSING; LIVER METABOLISM; METABOLIC DISORDER; NAUSEA; NEWBORN APNEA; OFF LABEL DRUG USE; PEDIATRICS; PHOCOMELIA; PLASMA CLEARANCE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TERATOGENESIS; TREATMENT RESPONSE;

CHILD; CHILD, PRESCHOOL; HUMANS; PEDIATRICS; PHARMACOLOGY, CLINICAL;

EID: 33846848912     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2007.00970.x     Document Type: Review

References (26)

1. Tan E, Cranswick NE, Rayner CR, Chapman CB. Dosing information for paediatric patients. Are they really therapeutic orphans? Med. J. Aust. 2003; 179: 195-8.
2. Lischner H, Seligman S, Krammer A, Parmelee A. An outbreak of neonatal deaths among term infants associated with administration of chloramphenicol. J. Pediatr. 1961; 59: 21-34.
3. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. Efficacy and safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-83.
4. Yaffe S, Aranda J. Introduction and historical perspectives. In: Yaffe S, Aranda J, eds. Pediatric Pharmacology: Therapeutic Principles in Practice, 2nd edn. Philadelphia, PA: Saunders, 1992; 3-9.
5. Kearns G, Abdel-Rahman S, Alander S, Blowey D, Leeder J, Kauffman R. Developmental pharmacology - drug disposition, action, and therapy in infants and children. N. Engl. J. Med. 2003; 349: 1157-67.
6. Christensen M, Helms R, Chesney R. Is pediatric labelling really necessary? Pediatrics 1999; 104: supplement to Pediatrics, Part 2 of 3: 593-7.
7. Yaffe MD, ed., Estabrook RW, Bouxsein P, Pitluck S, Davis JR. Rational Therapeutics for Infants and Children: Workshop Summary. Washington, DC: National Academy Press. Sumner Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Division of Health Sciences Policy, 2000.
8. Kearns G, Reed M. Clinical Pharmacokinetics in Infants and Children. A reappraisal. Clin. Pharmacokinet. 1989; 17 (Suppl. 1): 29-67.
9. Turner S. Unregistered and off-label drug use in paediatric inpatients. Aust. J. Hosp. Pharm. 1999; 29: 265-8.
10. Gazarian M, Kelly M, McPhee JR, Graudins LU, Ward RL, Campbell TJ. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med. J. Aust. 2006; 185: 544-8.
11. Turner S, Longworth A, Nunn A, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998; 316: 343-5.
12. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch. Dis. Child. Fetal Neonatal Ed. 1999; 80: F142-5.
13. American Academy of Pediatrics. Committee on drugs. Uses of drugs not described in the package insert (off-label uses). Pediatrics 2002; 110: 181-3.
14. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999; 88: 965-8.
15. Horen B, Montastruc J, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br. J. Clin. Pharmacol. 2002; 54: 665-70.
16. AHMAC Paediatric Pharmaceuticals Working Group.Interim Report, Vol. 1. June 2004. Available at: http://www.health.wa.gov.au/publications/ AHMACPaediatricPharmaceuticalsWorkingGroupInterimReport.pdf (accessed 18 May 2006).
17. Hill P. Off licence and off label prescribing in children: litigation fear for physicians. Arch. Dis. Child. 2005; 90 (Suppl. I): i17-i18.
18. Ventolin CFC-free inhaler.MIMS online. Available at: http://mims.hcn.net.au (accessed 18 May 2006).
19. Caldwell PHY, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet 2004; 364: 803-11.
20. Schreiner M. Paediatric clinical trials: redressing the imbalance. Nature Reviews. Drug Discov. 2003; 2: 949-61.
21. Roberts R, Rodriguez W, Murphy D, Crescenzi T. Pediatric drug labeling. Improving the safety and efficacy of pediatric therapies. JAMA 2003; 290: 905-11.
22. Steinbrook R. Testing medication in children. N. Engl. J. Med. 2002; 347: 1462-70.
23. Caldwell PHY, Butow PN, Craig JC. Parents' attitudes to children's participation in randomized controlled trials. J. Pediatr. 2003; 142: 554-9.
24. Caldwell PHY, Butow PN, Craig JC. Pediatricians' attitudes toward randomized controlled trials involving children. J. Pediatr. 2002; 141: 798-803.
25. Lim A, Cranswick NE. Clinical trials, ethical issues and patient recruitment: an Australian perspective. Paediatr. Perinat Drug Ther. 2003; 5: 183-7.
26. Cohen S. The Pediatric Pharmacology Research Institute (PPRU) Network and its role in meeting pediatric labeling needs. Pediatrics 1999; 104: 644-5.